Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells

Elfrida R. Grant, Monica A. Errico, Stuart L. Emanuel, Daniel Benjamin, Michael K. McMillian, Scott A. Wadsworth, Robert A. Zivin, Zhong Zhong

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Excessive levels of the neurotransmitter glutamate trigger excitotoxic processes in neurons that lead to cell death. N-Methyl-D-aspartate (NMDA) receptor over-activation is a key excitotoxic stimulus that leads to increases in intracellular calcium and activation of downstream signaling pathways, including the p44/42 mitogen-activated protein (MAP) kinase pathway. In the present study, we have demonstrated that 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), a potent and selective inhibitor of the p44/42 MAP kinase signaling pathway, prevents glutamate-induced death in neuronally differentiated P19 cells. In addition, we show that differentiated, but not undifferentiated, P19 cells expressed zeta1, epsilon1, and epsilon2 subunits of the NMDA receptor. Differentiated P19 cells exhibited specific NMDA receptor binding and intracellular calcium responses to glutamate that were blocked by the selective NMDA receptor antagonist [5R,10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), but not U0126. Glutamate treatment of differentiated P19 cells triggered a rapid and sustained induction in p42 MAP kinase phosphorylation that was blocked by U0126. Pretreatment of differentiated P19 cells with U0126, but not other classes of protein kinase inhibitors, protected against glutamate-induced cell death. Post-treatment with U0126, even as late as 6 hr after glutamate application, also protected against glutamate toxicity. These results suggest that the p44/42 MAP kinase pathway may be a critical downstream signaling pathway in glutamate receptor-activated toxicity.

Original languageEnglish
Pages (from-to)283-296
Number of pages14
JournalBiochemical Pharmacology
Volume62
Issue number3
DOIs
StatePublished - Aug 1 2001

Fingerprint

Mitogen-Activated Protein Kinases
Toxicity
Glutamic Acid
N-Methyl-D-Aspartate Receptors
Cell death
Cell Death
Chemical activation
Calcium
Phosphorylation
Imines
Dizocilpine Maleate
Mitogen-Activated Protein Kinase 1
Glutamate Receptors
Protein Kinase Inhibitors
Neurons
Neurotransmitter Agents
U 0126

Keywords

  • Glutamate
  • N-Methyl-D-aspartate
  • Neuroprotection
  • P44/42 MAP kinase
  • Phosphorylation
  • U0126

ASJC Scopus subject areas

  • Pharmacology

Cite this

Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells. / Grant, Elfrida R.; Errico, Monica A.; Emanuel, Stuart L.; Benjamin, Daniel; McMillian, Michael K.; Wadsworth, Scott A.; Zivin, Robert A.; Zhong, Zhong.

In: Biochemical Pharmacology, Vol. 62, No. 3, 01.08.2001, p. 283-296.

Research output: Contribution to journalArticle

Grant, Elfrida R. ; Errico, Monica A. ; Emanuel, Stuart L. ; Benjamin, Daniel ; McMillian, Michael K. ; Wadsworth, Scott A. ; Zivin, Robert A. ; Zhong, Zhong. / Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells. In: Biochemical Pharmacology. 2001 ; Vol. 62, No. 3. pp. 283-296.
@article{7876775e72e348de94e45ab09c408ccc,
title = "Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells",
abstract = "Excessive levels of the neurotransmitter glutamate trigger excitotoxic processes in neurons that lead to cell death. N-Methyl-D-aspartate (NMDA) receptor over-activation is a key excitotoxic stimulus that leads to increases in intracellular calcium and activation of downstream signaling pathways, including the p44/42 mitogen-activated protein (MAP) kinase pathway. In the present study, we have demonstrated that 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), a potent and selective inhibitor of the p44/42 MAP kinase signaling pathway, prevents glutamate-induced death in neuronally differentiated P19 cells. In addition, we show that differentiated, but not undifferentiated, P19 cells expressed zeta1, epsilon1, and epsilon2 subunits of the NMDA receptor. Differentiated P19 cells exhibited specific NMDA receptor binding and intracellular calcium responses to glutamate that were blocked by the selective NMDA receptor antagonist [5R,10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), but not U0126. Glutamate treatment of differentiated P19 cells triggered a rapid and sustained induction in p42 MAP kinase phosphorylation that was blocked by U0126. Pretreatment of differentiated P19 cells with U0126, but not other classes of protein kinase inhibitors, protected against glutamate-induced cell death. Post-treatment with U0126, even as late as 6 hr after glutamate application, also protected against glutamate toxicity. These results suggest that the p44/42 MAP kinase pathway may be a critical downstream signaling pathway in glutamate receptor-activated toxicity.",
keywords = "Glutamate, N-Methyl-D-aspartate, Neuroprotection, P44/42 MAP kinase, Phosphorylation, U0126",
author = "Grant, {Elfrida R.} and Errico, {Monica A.} and Emanuel, {Stuart L.} and Daniel Benjamin and McMillian, {Michael K.} and Wadsworth, {Scott A.} and Zivin, {Robert A.} and Zhong Zhong",
year = "2001",
month = "8",
day = "1",
doi = "10.1016/S0006-2952(01)00665-7",
language = "English",
volume = "62",
pages = "283--296",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells

AU - Grant, Elfrida R.

AU - Errico, Monica A.

AU - Emanuel, Stuart L.

AU - Benjamin, Daniel

AU - McMillian, Michael K.

AU - Wadsworth, Scott A.

AU - Zivin, Robert A.

AU - Zhong, Zhong

PY - 2001/8/1

Y1 - 2001/8/1

N2 - Excessive levels of the neurotransmitter glutamate trigger excitotoxic processes in neurons that lead to cell death. N-Methyl-D-aspartate (NMDA) receptor over-activation is a key excitotoxic stimulus that leads to increases in intracellular calcium and activation of downstream signaling pathways, including the p44/42 mitogen-activated protein (MAP) kinase pathway. In the present study, we have demonstrated that 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), a potent and selective inhibitor of the p44/42 MAP kinase signaling pathway, prevents glutamate-induced death in neuronally differentiated P19 cells. In addition, we show that differentiated, but not undifferentiated, P19 cells expressed zeta1, epsilon1, and epsilon2 subunits of the NMDA receptor. Differentiated P19 cells exhibited specific NMDA receptor binding and intracellular calcium responses to glutamate that were blocked by the selective NMDA receptor antagonist [5R,10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), but not U0126. Glutamate treatment of differentiated P19 cells triggered a rapid and sustained induction in p42 MAP kinase phosphorylation that was blocked by U0126. Pretreatment of differentiated P19 cells with U0126, but not other classes of protein kinase inhibitors, protected against glutamate-induced cell death. Post-treatment with U0126, even as late as 6 hr after glutamate application, also protected against glutamate toxicity. These results suggest that the p44/42 MAP kinase pathway may be a critical downstream signaling pathway in glutamate receptor-activated toxicity.

AB - Excessive levels of the neurotransmitter glutamate trigger excitotoxic processes in neurons that lead to cell death. N-Methyl-D-aspartate (NMDA) receptor over-activation is a key excitotoxic stimulus that leads to increases in intracellular calcium and activation of downstream signaling pathways, including the p44/42 mitogen-activated protein (MAP) kinase pathway. In the present study, we have demonstrated that 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), a potent and selective inhibitor of the p44/42 MAP kinase signaling pathway, prevents glutamate-induced death in neuronally differentiated P19 cells. In addition, we show that differentiated, but not undifferentiated, P19 cells expressed zeta1, epsilon1, and epsilon2 subunits of the NMDA receptor. Differentiated P19 cells exhibited specific NMDA receptor binding and intracellular calcium responses to glutamate that were blocked by the selective NMDA receptor antagonist [5R,10S]-[+]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), but not U0126. Glutamate treatment of differentiated P19 cells triggered a rapid and sustained induction in p42 MAP kinase phosphorylation that was blocked by U0126. Pretreatment of differentiated P19 cells with U0126, but not other classes of protein kinase inhibitors, protected against glutamate-induced cell death. Post-treatment with U0126, even as late as 6 hr after glutamate application, also protected against glutamate toxicity. These results suggest that the p44/42 MAP kinase pathway may be a critical downstream signaling pathway in glutamate receptor-activated toxicity.

KW - Glutamate

KW - N-Methyl-D-aspartate

KW - Neuroprotection

KW - P44/42 MAP kinase

KW - Phosphorylation

KW - U0126

UR - http://www.scopus.com/inward/record.url?scp=0035427631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035427631&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(01)00665-7

DO - 10.1016/S0006-2952(01)00665-7

M3 - Article

C2 - 11434901

AN - SCOPUS:0035427631

VL - 62

SP - 283

EP - 296

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 3

ER -